Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 delta pseudogene 3 (EEF1DP3)
- Target
- EEF1DP3
- Molecular classification
- Other (Pseudogene; not an active receptor, enzyme, transporter, etc.)
01
Overview
EEF1DP3 (Eukaryotic translation elongation factor 1 delta pseudogene 3) is a human pseudogene related by sequence homology to the elongation factor 1-delta gene (EEF1D), which encodes a component of the eEF1B complex responsible for nucleotide exchange during protein translation elongation[4][6][8]. EEF1DP3 itself is classified as a pseudogene, meaning that although it shares sequence similarity with protein-coding genes, it does not produce a functional protein and has no established biological role. It is not considered a therapeutic target, is not implicated in disease, and does not interact with drugs or function as a biomarker[6][8][9]. The corresponding protein-coding gene, EEF1D, is involved in cellular processes related to translation, cell proliferation, and may act as a proto-oncogene in certain cancers[1][4], but EEF1DP3 should not be confused with the functional EEF1D.
- Other names
- Putative elongation factor 1-delta-like proteinPutative EF-1-delta-like pseudogene 3 proteinEEF1DP3
02
Mechanism of action
null; not a therapeutic target
03
Biological functions
none established; predicted activity based on homology, does not have demonstrated protein product or function
04
Disease associations
none known; no evidence for involvement in disease, unlike its protein-coding paralogues
05
Safety considerations
null; not a drug target, no associated safety concerns
06
Interacting drugs
none; no known drug interactions
07
Biomarkers
null; not a validated biomarker
Beyond the preview
Go deeper on Eukaryotic translation elongation factor 1 delta pseudogene 3 (EEF1DP3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 delta pseudogene 3 (EEF1DP3).